> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Updates Woodside Acquisitions’ Covid Tests Recall
- URL: https://www.fdaweb.com/fda-updates-woodside-acquisitions-covid-tests-recall/
- Published: 2022-06-10T12:00:00.000Z
- Updated: 2026-09-14T17:48:14.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152030

FDA has updated a Class 1 [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/woodside-acquisitions-inc-recalls-oral-rapid-sars-cov-2-antigen-rapid-test-kits-and-joysbio-sars-cov?ref=fdaweb.com) involving Woodside Acquisitions’ Oral Rapid SARS-CoV-2 Antigen Rapid Test Kit and the Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold). The notice says the firm’s name does not appear on the tests’ labels. It also clarifies that the tests were not authorized, cleared, or approved by FDA, and there are not sufficient data demonstrating that test’s performance is accurate, which increases the risk of potential false negative, false positive, or misinterpretation of results.